Germany GLP-1 Drugs Market Trends The use of GLP-1 drugs in Germany is increasing due to growing incidences of type 2 diabetes as well as obesity
"Diabetes and obesity are big things that we should be treating, the downstream cost of care is huge," said Timothy Law, chief medical officer for Highmark, on a GLP-1 panel at AHIP
While these medications are effective tools for weight management, finding out whether you qualify for coverage can be a time-consuming, and sometimes confusing process
I feel very comfortable every time I go in
(6)(7) For example, researchers such as Huff et al
This is normal for any medication, but its worth being aware of